Maftivimab (REGN3470-3471-3479), also known as Atoltivimab and Odesivimab under the brand name Inmazeb, is an FDA-approved monoclonal antibody cocktail designed to inhibit Filovirus activity. This biologic is specifically targeted against the Zaire ebolavirus, making it highly relevant for research focused on this pathogen. Maftivimab is utilized in studies investigating the mechanisms of viral entry and replication, as well as in the development of therapeutic strategies for Ebola virus infection.
Maftivimab (REGN3470-3471-3479), also known as Atoltivimab and Odesivimab under the brand name Inmazeb, is an FDA-approved monoclonal antibody cocktail designed to inhibit Filovirus activity. This biologic is specifically targeted against the Zaire ebolavirus, making it highly relevant for research focused on this pathogen. Maftivimab is utilized in studies investigating the mechanisms of viral entry and replication, as well as in the development of therapeutic strategies for Ebola virus infection.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: